A citation-based method for searching scientific literature

Anna F Farago, Long P Le, Zongli Zheng, Alona Muzikansky, Alexander Drilon, Manish Patel, Todd M Bauer, Stephen V Liu, Sai-Hong I Ou, David Jackman, Daniel B Costa, Pratik S Multani, Gary G Li, Zachary Hornby, Edna Chow-Maneval, David Luo, Jonathan E Lim, Anthony J Iafrate, Alice T Shaw. J Thorac Oncol 2015
Times Cited: 144



A Vaishnavi, M Capelletti, A T Le, S Kako, M Butaney, D Ercan, S Mahale, K D Davies, D L Aisner, A B Pilling, E M Berge, J Kim, H Sasaki, S Park, G Kryukov, L A Garraway, Peter S Hammerman, J Haas, S W Andrews, D Lipson, P J Stephens, V A Miller, M Varella-Garcia, P A Jänne, R C Doebele. Nat Med 2013
Times Cited: 356




List of shared articles



Times cited

Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer.
Hedvig Elfving, Erika Broström, Lotte N J Moens, Jonas Almlöf, Dijana Cerjan, Gilbert Lauter, Helena Nord, Johanna S M Mattsson, Gustav J Ullenhag, Carina Strell,[...]. Lung Cancer 2021
3

An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology.
Nicolas Piton, Marie-Delphine Lanic, Florent Marguet, Aude Lamy, France Blanchard, Florian Guisier, Mathieu Viennot, Mathieu Salaün, Luc Thiberville, Fabrice Jardin,[...]. Lab Invest 2021
0

Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers.
Tingting Jiang, Guan Wang, Yao Liu, Lu Feng, Meng Wang, Jie Liu, Yi Chen, Liang Ouyang. Acta Pharm Sin B 2021
11

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli,[...]. Crit Rev Oncol Hematol 2021
0

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
Ruiying Zhao, Feng Yao, Chan Xiang, Jikai Zhao, Zhanxian Shang, Lianying Guo, Wenjie Ding, Shengji Ma, Anbo Yu, Jinchen Shao,[...]. J Pathol Clin Res 2021
0

Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma.
Simon Strohmeier, Iva Brcic, Helmut Popper, Bernadette Liegl-Atzwanger, Jörg Lindenmann, Luka Brcic. Sci Rep 2021
1

Molecular Pathology of Lung Cancer.
Sinchita Roy-Chowdhuri. Surg Pathol Clin 2021
0

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
Derek Wong, Stephen Yip, Poul H Sorensen. Pathol Oncol Res 2020
16


Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T Shaw, Anna F Farago, Collin M Blakely, Takashi Seto, Byung Chul Cho, Diego Tosi,[...]. Lancet Oncol 2020
267

Entrectinib for the treatment of metastatic NSCLC: safety and efficacy.
Andrea Sartore-Bianchi, Elio Gregory Pizzutilo, Giovanna Marrapese, Federica Tosi, Giulio Cerea, Salvatore Siena. Expert Rev Anticancer Ther 2020
9

Molecular Targets Beyond the Big 3.
Karen L Reckamp. Thorac Surg Clin 2020
3

NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine.
Federica Zito Marino, Francesca Pagliuca, Andrea Ronchi, Immacolata Cozzolino, Marco Montella, Massimiliano Berretta, Maria Elena Errico, Vittoria Donofrio, Roberto Bianco, Renato Franco. Int J Mol Sci 2020
14

Histology-agnostic drug development - considering issues beyond the tissue.
Roberto Carmagnani Pestana, Shiraj Sen, Brian P Hobbs, David S Hong. Nat Rev Clin Oncol 2020
17

Primary Resistance to Brigatinib in a Patient with Lung Adenocarcinoma Harboring ALK G1202R Mutation and LIPI-NTRK1 Rearrangement.
Zhiwei Xiao, Xuewu Huang, Biyuan Xie, Wenzhuan Xie, Mengli Huang, Lizhu Lin. Onco Targets Ther 2020
2

[Fusion transcripts: Therapeutic targets in thoracic oncology].
Audrey Mansuet-Lupo, Simon Garinet, Diane Damotte, Marco Alifano, Hélène Blons, Marie Wislez, Karen Leroy. Bull Cancer 2020
0

Molecular Pathology of Primary Non-small Cell Lung Cancer.
David Ilan Suster, Mari Mino-Kenudson. Arch Med Res 2020
3


Molecular characterization of cancers with NTRK gene fusions.
Zoran Gatalica, Joanne Xiu, Jeffrey Swensen, Semir Vranic. Mod Pathol 2019
177

Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application.
Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, Massimo Santoro, Neil Q McDonald, Fengping Lv, Naresh Gunaganti, Brendan Frett, Hong-Yu Li. J Med Chem 2019
24

TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.
Catherine M Albert, Jessica L Davis, Noah Federman, Michela Casanova, Theodore W Laetsch. J Clin Oncol 2019
37

Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer.
Jessica M Konen, B Leticia Rodriguez, Jared J Fradette, Laura Gibson, Denali Davis, Rosalba Minelli, Michael D Peoples, Jeffrey Kovacs, Alessandro Carugo, Christopher Bristow,[...]. Cancers (Basel) 2019
13


Targeting tropomyosin receptor kinase for cancer therapy.
Qi Miao, Kun Ma, Dong Chen, Xiaoxing Wu, Sheng Jiang. Eur J Med Chem 2019
5

Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence.
Biagio Ricciuti, Carlo Genova, Lucio Crinò, Massimo Libra, Giulia Costanza Leonardi. Onco Targets Ther 2019
22

ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
C Marchiò, M Scaltriti, M Ladanyi, A J Iafrate, F Bibeau, M Dietel, J F Hechtman, T Troiani, F López-Rios, J-Y Douillard,[...]. Ann Oncol 2019
102


Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer.
A Amatu, A Sartore-Bianchi, K Bencardino, E G Pizzutilo, F Tosi, S Siena. Ann Oncol 2019
32

Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3-Positive Acute Myeloid Leukemia.
Kristen M Smith, Patrick C Fagan, Elena Pomari, Giuseppe Germano, Chiara Frasson, Colin Walsh, Ian Silverman, Paolo Bonvini, Gang Li. Mol Cancer Ther 2018
21

Molecular pathology of lung cancer: current status and perspectives.
Felicitas Oberndorfer, Leonhard Müllauer. Curr Opin Oncol 2018
44

Foretinib Overcomes Entrectinib Resistance Associated with the NTRK1 G667C Mutation in NTRK1 Fusion-Positive Tumor Cells in a Brain Metastasis Model.
Akihiro Nishiyama, Tadaaki Yamada, Kenji Kita, Rong Wang, Sachiko Arai, Koji Fukuda, Azusa Tanimoto, Shinji Takeuchi, Shoichiro Tange, Atsushi Tajima,[...]. Clin Cancer Res 2018
14

Inhibiting TRK Proteins in Clinical Cancer Therapy.
Allison M Lange, Hui-Wen Lo. Cancers (Basel) 2018
69

Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib.
Biagio Ricciuti, Andrea De Giglio, Carmen Mecca, Cataldo Arcuri, Sabrina Marini, Giulio Metro, Sara Baglivo, Angelo Sidoni, Guido Bellezza, Lucio Crinò,[...]. Med Oncol 2018
18



Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?
Simon Garinet, Pierre Laurent-Puig, Hélène Blons, Jean-Baptiste Oudart. J Clin Med 2018
31

Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins.
Ed S Kheder, David S Hong. Clin Cancer Res 2018
56

Emerging targets in advanced non-small-cell lung cancer.
Francesco Valentino, Gloria Borra, Paolo Allione, Lorena Rossi. Future Oncol 2018
11

Integrated genetic and epigenetic analysis of myxofibrosarcoma.
Koichi Ogura, Fumie Hosoda, Yasuhito Arai, Hiromi Nakamura, Natsuko Hama, Yasushi Totoki, Akihiko Yoshida, Momoko Nagai, Mamoru Kato, Erika Arakawa,[...]. Nat Commun 2018
25

Larotrectinib (LOXO-101).
Stephanie Berger, Uwe M Martens, Sylvia Bochum. Recent Results Cancer Res 2018
11


Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion.
Anna F Farago, Martin S Taylor, Robert C Doebele, Viola W Zhu, Shivaani Kummar, Alexander I Spira, Theresa A Boyle, Eric B Haura, Maria E Arcila, Ryma Benayed,[...]. JCO Precis Oncol 2018
77

TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.
Shivaani Kummar, Ulrik N Lassen. Target Oncol 2018
43

Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics.
Ryosuke Okamura, Amélie Boichard, Shumei Kato, Jason K Sicklick, Lyudmila Bazhenova, Razelle Kurzrock. JCO Precis Oncol 2018
118